ID journal club: Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial
Fellow: Ophat J.
9.00 – 10.00 a.m.
I.D. Conference Room, 5th floor, Bhumisiri mangkhalanusorn building
For more, please visit
http://www.idchula.org/
